Publication | Open Access

Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1/2 signaling pathway in normal and neoplastic B-lymphoid cells

Cancer ResearchSignaling PathwayNeoplastic B-lymphoid CellsCell RegulationMedicineImmunologyCell DeathBaff-stimulated Cell ProliferationTumor SuppressorCancer BiologyCell BiologyCell SignalingTumor Biology